# US 2006/0069268 A1 · Process for the manufacture of valsartan

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0069268 A1
- Document ID: US20060069268A1
- Status: Published application
- Kind: A1
- Application number: 10/528,323
- Filed: 2003-09-22
- Published: 2006-03-30
- Earliest claimed: 2002-09-23
- Inventors: Donatienne Denni-Dischert; Hans Hirt; Dan Neville; Gottfried Sedelmeier; Anita Schnyder; Nadine Derrien; Daniel Kaufmann
- Web page: https://patentgrep.com/patent/US20060069268A1

## CPC

- C07D 257/04: Five-membered rings
- A61P 9/12: Antihypertensives
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention relates to a process for the manufacture of an angiotensin receptor blocker (ARB; also called angiotension II receptor antagonist or AT1 receptor antagonist) and salts thereof, to novel intermediates and process steps.

## Claims

### Claim 1

A process for the manufacture of the compound of formula (I)
or a salt thereof, comprising
(a) reacting a compound of formula (II a)
or a salt thereof, wherein R1 is hydrogen or a tetrazole protecting group, with a compound of formula
or a salt thereof, wherein R2 represents hydrogen or a carboxy protecting group, under the conditions of a reductive amination; and
(b) acylating a resulting compound of formula (II c)
or a salt thereof with a compound of formula (II d)
wherein R3 is an activating group; and,
(c) if R1 and/or R2 are different form hydrogen, removing the protecting group(s) in a resulting compound of formula (II e)
or a salt thereof; and
(d) isolating a resulting compound of formula (I) or a salt thereof; and, if desired, converting a resulting free acid of formula (I) into a salt thereof or converting a resulting salt of a compound of formula (I) into the free acid of formula (I) or converting a resulting salt of a compound of formula (I) into a different salt.

### Claim 2 (depends on 1)

The process according to claim 1, wherein in compounds of formulae (II a), (II b), (II c), and (II e) R1 represents hydrogen and R2 represents hydrogen and wherein in compounds of formula (II d) R3 represents halogen.

### Claim 3 (depends on 1)

The process according to claim 1, wherein the reductive amination is carried out in the presence of a reducing agent such as a borohydride, which may also be in complexed form, or hydrogen or a hydrogen donor both in the presence of a hydrogenation catalyst.

### Claim 4 (depends on 1)

The process according to claim 1, wherein step (a) is carried out by first forming an imine of formula
by condensing compounds of formulae (II a) and (II b) and by removing water and then followed by reducing a compound of formula (II c′) in the presence of a reducing agent.

### Claim 5 (depends on 1)

The process according to claim 1, wherein step (b) is carried out by first adding a compound of formula (II d) to a compound of formula (II c) and then slowly adding a sub-stoichiometric amount of a base in relation to the compound of formula (II d).

### Claim 6

A process for the manufacture of a compound of formula
wherein R1 represents hydrogen or a tetrazole protecting group and R2 represents hydrogen or a carboxy protecting group,
comprising reacting a compound of formula (II a)
or a salt thereof, wherein R1 is hydrogen or a tetrazole protecting group, with a compound of formula
or a salt thereof, wherein R2 represents hydrogen or a carboxy protecting group, under the conditions of a reductive amination.

### Claim 7 (depends on 6)

A process according to claim 6, comprising reacting a compound of formula (II a)
or a salt thereof, wherein R1 is hydrogen or a tetrazole protecting group, with a compound of formula
or a salt thereof, wherein R2 represents hydrogen or a carboxy protecting group, while eliminating water, and reducing a resulting compound of formula (II c′)
in the presence of a reducing agent.

### Claim 8

A compound of formula
wherein R1 is hydrogen or a tetrazole protecting group and R2 is hydrogen or a carboxy protecting group, excluding a compound of formula (II c) wherein R1 is ethyl and R2 is trityl.

### Claim 9

A compound of formula
wherein R1 is hydrogen or a tetrazole protecting group and R2 is hydrogen or a carboxy protecting group.

### Claim 10

A process for the manufacture of a compound of formula
wherein R1 represents hydrogen or a tetrazole protecting group and R2 represents hydrogen or a carboxy protecting group,
comprising acylating a resulting compound of formula (II c)
or a salt thereof with a compound of formula (II d)
wherein R3 is an activating group.

### Claim 11 (depends on 2)

The process according to claim 2, wherein the reductive amination is carried out in the presence of a reducing agent such as a borohydride, which may also be in complexed form, or hydrogen or a hydrogen donor both in the presence of a hydrogenation catalyst.

### Claim 12 (depends on 2)

The process according to claim 2, wherein step (a) is carried out by first forming an imine of formula
by condensing compounds of formulae (II a) and (II b) and by removing water and then followed by reducing a compound of formula (II c) in the presence of a reducing agent.

### Claim 13 (depends on 2)

The process according to claim 2, wherein step (b) is carried out by first adding a compound of formula (II d) to a compound of formula (II c) and then slowly adding a substoichiometric amount of a base in relation to the compound of formula (II d).
